In further reports, mPGES-1 was proposed as a potentially promising target for the treatment of many other inflammation-related diseases such as osteoarthritis, rheumatoid arthritis and associated pain, cardiovascular diseases, and cancer25,37–44. This evidence concerns the gene PTGES and osteoarthritis.